Analysis And Perspectives

Eli’s Jaypirca: A Beacon of Success in the BTK Inhibitor Market

FDA granted accelerated approval to Lilly’s Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma patients.

Find More
Unraveling the Complexities of Dermatomyositis Treatment: A Comprehensive Review and Future Perspectives

In the last two decades, many advancement yielded new insights, paving way for promising therapeutic approaches for dermatomyositis treatment.

Find More
Could Amgen’s Biosimilar Wezlana Pose a Challenge to Johnson & Johnson’s Stelara

FDA recently approved Amgen’s Wezlana for various inflammatory conditions, marking the first biosimilar approval referencing the J&J Stelara.

Find More
Cryotherapy Market Analysis
Navigating the Booming Cryotherapy Market and Its Future Outlook

Cryotherapy, a therapeutic technique utilizing extreme cold temperatures, has witnessed a significant evolution catalyzed by technological advancements, propelling its prominence in the healthcare industry. The integration of cutting-edge technology has revolutionized cryotherapy, enabling precise temperature contr...

Find More
Another Feather in the Cap for Xtandi and Keytruda — The Two Main Cancer Drugs

The FDA has granted label extensions for two of the most vital global cancer drugs—Merck’s Keytruda and Pfizer and Astellas’ Xtandi.

Find More
Novartis Cosentyx: First Biologic Hidradenitis Suppurativa Treatment After Almost Ten Years

On October 31, FDA approved Cosentyx hidradenitis suppurativa treatment, marking first approval of new biologic in nearly a decade.

Find More
Joint Reconstruction Devices Market Analysis
Innovative Pathways in Joint Reconstruction: Market Dynamics and Future Horizons

In recent years, the joint reconstruction devices market within the realm of orthopedics has undergone a profound evolution, owing to the technological advancements and innovations that have revolutionized treatment modalities and patient outcomes to a much greater extent. The intersection of innovative technologie...

Find More
Phathom Secures Dual FDA Approvals for Voquezna Following Impurity Setback

Within a three-day period, Phathom Pharmaceuticals achieves dual FDA approvals for Voquezna, its groundbreaking heartburn medication.

Find More
The Next Chapter in NSCLC Treatment Space: Recent Discoveries and Innovations

The evolving landscape of NSCLC treatment presents significant market opportunities for pharmaceutical companies to secure their place.

Find More
Rehabilitation Equipment Market Analysis
Evaluating the Growing Role of Rehabilitation Equipment in Revitalizing Lives and Improving the Treatment Outcome

Rehabilitation equipment, a cornerstone in the realm of healthcare, has undergone a remarkable evolution over the years, propelled by the rising demand and their potential to improve patient outcomes and restore quality of life. From rudimentary tools and manual therapies to the present-day sophisticated, technolog...

Find More